What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His primary scientific interests are in Genetics, Prostate cancer, Single-nucleotide polymorphism, Internal medicine and Genome-wide association study.
Locus, Genetic linkage, Allele, Genetic association and Genotype are the primary areas of interest in his Genetics study.
His biological study spans a wide range of topics, including Cancer research, Prostate, Disease and Germline mutation.
His study in Single-nucleotide polymorphism is interdisciplinary in nature, drawing from both Odds ratio, Haplotype, Immunology and Allele frequency.
His work deals with themes such as Endocrinology and Oncology, which intersect with Internal medicine.
His research in Genome-wide association study intersects with topics in Body mass index and Genetic model.
His most cited work include:
- Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index (2348 citations)
- Hundreds of variants clustered in genomic loci and biological pathways affect human height (1614 citations)
- Inflammation in prostate carcinogenesis (1224 citations)
What are the main themes of his work throughout his whole career to date?
Jianfeng Xu focuses on Prostate cancer, Internal medicine, Oncology, Genetics and Single-nucleotide polymorphism.
His studies deal with areas such as Cancer research, Prostate, Gynecology and Genotype as well as Prostate cancer.
His Internal medicine study typically links adjacent topics like Endocrinology.
His Oncology research incorporates themes from Germline mutation, Germline, Disease, Prostate cancer risk and Cohort.
He combines subjects such as Genotyping and Haplotype with his study of Single-nucleotide polymorphism.
Jianfeng Xu has included themes like Genetic variation, Genetic association, Bioinformatics and Genetic predisposition in his Genome-wide association study study.
He most often published in these fields:
- Prostate cancer (59.71%)
- Internal medicine (54.74%)
- Oncology (40.44%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (54.74%)
- Oncology (40.44%)
- Prostate cancer (59.71%)
In recent papers he was focusing on the following fields of study:
Jianfeng Xu spends much of his time researching Internal medicine, Oncology, Prostate cancer, Germline and Single-nucleotide polymorphism.
His research in Internal medicine focuses on subjects like Germline mutation, which are connected to DNA repair, Exome and Mutation Carrier.
His Oncology research is multidisciplinary, incorporating elements of Bladder cancer, Logistic regression, Genetic risk, Biopsy and Cohort.
The Prostate cancer study combines topics in areas such as Cancer research, Prostate, Disease, Breast cancer and Genetic testing.
Jianfeng Xu focuses mostly in the field of Single-nucleotide polymorphism, narrowing it down to matters related to Cancer screening and, in some cases, Genotype-phenotype distinction and Thyroid cancer.
Genetic association is the subject of his research, which falls under Genetics.
Between 2017 and 2021, his most popular works were:
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)
- Biallelic Mutations in MYORG Cause Autosomal Recessive Primary Familial Brain Calcification. (67 citations)
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. (49 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Jianfeng Xu mainly focuses on Internal medicine, Oncology, Prostate cancer, Mutation and Germline mutation.
His Internal medicine study integrates concerns from other disciplines, such as MEDLINE and Population study.
In his study, which falls under the umbrella issue of Oncology, Standard of care and Genetic profile is strongly linked to Germline.
His Prostate cancer research is multidisciplinary, incorporating perspectives in Cancer research, Carcinogenesis, Disease, Family history and Genetic testing.
His Germline mutation study incorporates themes from Exome, Mutation Carrier and DNA repair.
The subject of his Single-nucleotide polymorphism research is within the realm of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
